These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30187153)

  • 1. Individualized Dosing of Therapeutic Monoclonal Antibodies-a Changing Treatment Paradigm?
    Strik AS; Wang YC; Ruff LE; Yashar W; Messmer BT; Mould DR
    AAPS J; 2018 Sep; 20(6):99. PubMed ID: 30187153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dashboards for Therapeutic Monoclonal Antibodies: Learning and Confirming.
    Mould DR; Upton RN; Wojciechowski J; Phan BL; Tse S; Dubinsky MC
    AAPS J; 2018 Jun; 20(4):76. PubMed ID: 29904814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Influencing Drug Disposition of Monoclonal Antibodies in Inflammatory Bowel Disease: Implications for Personalized Medicine.
    Lefevre PLC; Shackelton LM; Vande Casteele N
    BioDrugs; 2019 Oct; 33(5):453-468. PubMed ID: 31301024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Modeling and Simulation of Biologicals in Inflammatory Bowel Disease: The Dawning of a New Era for Personalized Treatment.
    Dreesen E; Gils A; Vermeire S
    Curr Drug Targets; 2018; 19(7):757-776. PubMed ID: 26953243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing therapeutic drug monitoring in inflammatory bowel disease: a focus on therapeutic monoclonal antibodies.
    Papamichael K; Cheifetz AS
    Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1423-1431. PubMed ID: 34996330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit From Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling.
    Passot C; Pouw MF; Mulleman D; Bejan-Angoulvant T; Paintaud G; Dreesen E; Ternant D
    Ther Drug Monit; 2017 Aug; 39(4):322-326. PubMed ID: 28703717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease.
    Carman N; Mack DR; Benchimol EI
    Curr Gastroenterol Rep; 2018 Apr; 20(5):18. PubMed ID: 29623442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring in patients on biologics: lessons from gastroenterology.
    Papamichael K; Cheifetz AS
    Curr Opin Rheumatol; 2020 Jul; 32(4):371-379. PubMed ID: 32412995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies.
    Steenholdt C; Bendtzen K; Brynskov J; Ainsworth MA
    Inflamm Bowel Dis; 2016 Aug; 22(8):1999-2015. PubMed ID: 27135483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of monoclonal antibodies in inflammatory and malignant disease: Translating TNF-α experience to oncology.
    Oude Munnink TH; Henstra MJ; Segerink LI; Movig KL; Brummelhuis-Visser P
    Clin Pharmacol Ther; 2016 Apr; 99(4):419-31. PubMed ID: 26265133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System.
    Eser A; Primas C; Reinisch S; Vogelsang H; Novacek G; Mould DR; Reinisch W
    J Clin Pharmacol; 2018 Jun; 58(6):790-802. PubMed ID: 29381220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease: An Answer to Optimized Treatment?
    Hoseyni H; Xu Y; Zhou H
    J Clin Pharmacol; 2018 Jul; 58(7):864-876. PubMed ID: 29462502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in clearance monitoring of monoclonal antibodies in patients with inflammatory bowel diseases.
    Kantasiripitak W; Wang Z; Spriet I; Ferrante M; Dreesen E
    Expert Rev Clin Pharmacol; 2021 Dec; 14(12):1455-1466. PubMed ID: 35034509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases.
    Vande Casteele N; Herfarth H; Katz J; Falck-Ytter Y; Singh S
    Gastroenterology; 2017 Sep; 153(3):835-857.e6. PubMed ID: 28774547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Dosing of Infliximab in Patients With Inflammatory Bowel Disease Using a Bayesian Approach: A Next Step in Therapeutic Drug Monitoring.
    Desai DC; Dherai AJ; Strik A; Mould DR
    J Clin Pharmacol; 2023 Apr; 63(4):480-489. PubMed ID: 36458468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients.
    Dubinsky MC; Phan BL; Singh N; Rabizadeh S; Mould DR
    AAPS J; 2017 Jan; 19(1):215-222. PubMed ID: 27739008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease.
    Papamichael K; Juncadella A; Wong D; Rakowsky S; Sattler LA; Campbell JP; Vaughn BP; Cheifetz AS
    J Crohns Colitis; 2019 Aug; 13(8):976-981. PubMed ID: 30689771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Evolving Evidence for Therapeutic Drug Monitoring of Monoclonal Antibodies in Inflammatory Bowel Disease.
    Sheasgreen C; Nguyen GC
    Curr Gastroenterol Rep; 2017 May; 19(5):19. PubMed ID: 28397129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives.
    Vande Casteele N; Feagan BG; Gils A; Vermeire S; Khanna R; Sandborn WJ; Levesque BG
    Curr Gastroenterol Rep; 2014 Apr; 16(4):378. PubMed ID: 24595615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring-based dosing of TNF inhibitors in inflammatory bowel disease: the way forward?
    Strik AS; Berends SE; Löwenberg M
    Expert Rev Clin Pharmacol; 2019 Sep; 12(9):885-891. PubMed ID: 31305158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.